Global NGS Sample Preparation market expected to propel by the growing adoption of NGS sample preparation in developing innovative diagnostic tools and tests and development of precision & personalized medicines
Global NGS Sample Preparation market predicted to grow with a noteworthy rate during the forecast period, 2020-2027, on account of the rise in the incidence of diseases like cancer and the growing use of NGS for diagnostic purposes in cancer and management or treatment of disease. Additionally, the advancements in NSG platforms, declining cost of sequencing, and NSG platforms and improving regulatory for NSG based diagnostic tests. Moreover, the evolution of integrated and automated informatics and mechanical protocols based NGS sample preparation as it enhances sequencing speed & capacity, and sample tracking will lead to the robust growth of the NGS sample preparation market in the future time.
Furthermore, the growing R&D activities for developing therapies utilized in the treatment of genetic diseases across the developing and developed countries will accelerate the growth of the NGS sample preparation industry. The application of next-generation sequencing technology help in deciphering human diseases, especially in cancer. The rapid development of next-generation sequencing (NGS) has greatly reduced the cost of sequencing and achieved high throughput, which allows obtaining the sequence of the entire genome and all the genome information of those patients who are clinically diagnosed. In addition, the growing usage of NGS tools design therapies according to the nature of the disease, which helped the pharmaceutical and biopharmaceutical companies, thereby boosting the growth of the NGS sample preparation industry.
Product Overview in the Global NGS Sample Preparation Market
Based on the product, the global NGS Sample Preparation market categorized into Reagent & Consumables and NGS Workstations. The Reagent & Consumables segment likely to lead the market by 2027, as they are widespread throughout the sample preparation process and decreasing cost of sequencing, NGS platforms, and the growing applications of NGS in various fields such as drug and discovery, diagnostics, agro-genomics, and animal research, etc.
Technology Overview in the Global NGS Sample Preparation market
Based on technology, the global NGS Sample Preparation market classified into Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing (Smrt), Nanopore Sequencing, and Others. The sequencing by synthesis (SBS) segment accounted for a higher market share in 2019. It will continue to dominate the market by 2027, owing it is cost-effective, scalable, high yield of the sample, and are simple to operate.
Workflow Overview in the Global NGS Sample Preparation market
Based on workflow, the global NGS Sample Preparation market classified into Library Preparation [DNA, RNA], Target Enrichment (Targeted Sequencing, Whole Exome Sequencing, and Others), and Quality Control. Target Enrichment will be the fastest-growing segment, attributable to it help in providing a detailed view of the genome, including coding and non-coding genomic regions, and helps to provide comprehensive approaches to examine the impact of DNA sequence variations on human diversity.
Application Overview in the Global NGS Sample Preparation Market
Based on application, the global NGS Sample Preparation market categorized into Diagnosis (Infectious Disease, Cancer Diagnostics, and Reproductive Health Diagnostics), Drug Discovery, Agricultural & Animal Research, and Others. The Diagnosis segment projected to lead the market due to the rising number of new cancer cases across the world, and growing focus of key market players on developing NGS-based products & services for cancer and NIPT.
End-User Overview in the Global NGS Sample Preparation Market
Based on end-user, the global NGS Sample Preparation market categorized into Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Others. Academic Institutes & Research Centers segment estimated to dominate the market by 2027 on account of the extensive experiments and studies performed in research and academic centers to develop novel therapies.
Hospitals & Clinics segment will drive owing to the hospitals providing NGS for diagnosis of immune disorders, infectious diseases, non-invasive prenatal diagnosis, and in the detection of human hereditary disorders.
Regional Overview in the Global NGS Sample Preparation Market
By geography, the Global NGS Sample Preparation Market segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America is anticipated to witness a higher growth rate by 2027, owing to the presence of high R&D investment, technologically advanced healthcare research framework, simultaneous developments of personalized medicine and companion diagnostics along with the presence of key players in these regions.
Global NGS Sample Preparation Market: Competitive Landscape
Companies such as Illumina Inc., Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Inc., Beckman Coulter, Becton, Dickinson and Company, Pacific Biosciences of California, PerkinElmer Inc., F. Hoffmann-La Roche, New England Biolabs, Inc., and NuGEN Technologies, Inc. are the key players in the Global NGS Sample Preparation Market.
Global NGS Sample Preparation Market Report Content 1. Research Strategic Development 1.1. Market Modelling 1.2. Product Analysis 1.3. Market Trend and Economic Factors Analysis 1.4. Market Segmental Analysis 1.5. Geographical Mapping 1.6. Country Wise Segregation 2. Research Methodology 2.1. Identification of Target Market 2.2. Data Acquisition 2.3. Refining of Data/ Data Transformations 2.4. Data Validation through Primary Techniques 2.5. Exploratory Data Analysis 2.6. Graphical Techniques/Analysis 2.7. Quantitative Techniques/Analysis 2.8. Visual Result/Presentation 3. Executive Summary 4. Market Insights 4.1. Economic Factor Analysis 4.1.1. Drivers 4.1.2. Trends 4.1.3. Opportunities 4.1.4. Challenges 4.2. Technological Landscape 4.3. Competitors & Product Analysis 4.4. Regulatory Framework 4.5. Company market share analysis, 2019 4.6. Porter's Five forces analysis 4.7. New Investment Analysis 4.8. PESTEL Analysis 5. Global NGS Sample Preparation Market Overview 5.1. Market Size & Forecast, 2016-2027 5.1.1. Demand 5.1.1.1. By Value (USD Million) 5.2. Market Share & Forecast, 2016-2027 5.2.1. By Product 5.2.1.1. Reagent & Consumables 5.2.1.2. Workstations 5.2.2. By Workflow 5.2.2.1. Library Preparation 5.2.2.1.1. DNA 5.2.2.1.2. RNA 5.2.2.2. Target Enrichment 5.2.2.2.1. Targeted Sequencing 5.2.2.2.2. Whole Exome Sequencing 5.2.2.2.3. Others 5.2.2.3. Quality Control 5.2.3. By Technology 5.2.3.1. Sequencing By Synthesis (Sbs) 5.2.3.2. Ion Semiconductor Sequencing 5.2.3.3. Single-Molecule Real-Time Sequencing (Smrt) 5.2.3.4. Nanopore Sequencing 5.2.3.5. Others 5.2.4. By Application 5.2.4.1. Diagnosis 5.2.4.1.1. Infectious Disease 5.2.4.1.2. Cancer Diagnostics 5.2.4.1.3. Reproductive Health Diagnostics 5.2.4.2. Drug Discovery, 5.2.4.3. Agricultural & Animal Research 5.2.4.4. Others 5.2.5. By End-User 5.2.5.1. Academic Institutes & Research Centers 5.2.5.2. Hospitals & Clinics 5.2.5.3. Pharmaceutical & Biotechnology Companies 5.2.5.4. Others 5.2.6. By Region 5.2.6.1. North America 5.2.6.2. Europe 5.2.6.3. Asia Pacific 5.2.6.4. South America 5.2.6.5. Middle East & Africa 6. North America NGS Sample Preparation Market Overview 6.1. North America NGS Sample Preparation Market Size & Forecast, 2016-2027 6.1.1. Demand 6.1.1.1. By Value (USD Million) 6.2. North America NGS Sample Preparation Market Share & Forecast, 2016-2027 6.2.1. By Product 6.2.1.1. Reagent & Consumables 6.2.1.2. Workstations 6.2.2. By Workflow 6.2.2.1. Library Preparation 6.2.2.1.1. DNA 6.2.2.1.2. RNA 6.2.2.2. Target Enrichment 6.2.2.2.1. Targeted Sequencing 6.2.2.2.2. Whole Exome Sequencing 6.2.2.2.3. Others 6.2.2.3. Quality Control 6.2.3. By Technology 6.2.3.1. Sequencing By Synthesis (Sbs) 6.2.3.2. Ion Semiconductor Sequencing 6.2.3.3. Single-Molecule Real-Time Sequencing (Smrt) 6.2.3.4. Nanopore Sequencing 6.2.3.5. Others 6.2.4. By Application 6.2.4.1. Diagnosis 6.2.4.1.1. Infectious Disease 6.2.4.1.2. Cancer Diagnostics 6.2.4.1.3. Reproductive Health Diagnostics 6.2.4.2. Drug Discovery, 6.2.4.3. Agricultural & Animal Research 6.2.4.4. Others 6.2.5. By End-User 6.2.5.1. Academic Institutes & Research Centers 6.2.5.2. Hospitals & Clinics 6.2.5.3. Pharmaceutical & Biotechnology Companies 6.2.5.4. Others 6.2.6. By Country 6.2.6.1. US 6.2.6.2. Canada 6.2.6.3. Mexico 6.2.7. Company Market Share (Top 3-5) 6.2.8. Economic Impact Study on North America NGS Sample Preparation Market 7. Europe NGS Sample Preparation Market Overview 7.1. Europe NGS Sample Preparation Market Size & Forecast, 2016-2027 7.1.1. Demand 7.1.1.1. By Value (USD Million) 7.2. Europe NGS Sample Preparation Market Share & Forecast, 2016-2027 7.2.1. By Product 7.2.1.1. Reagent & Consumables 7.2.1.2. Workstations 7.2.2. By Workflow 7.2.2.1. Library Preparation 7.2.2.1.1. DNA 7.2.2.1.2. RNA 7.2.2.2. Target Enrichment 7.2.2.2.1. Targeted Sequencing 7.2.2.2.2. Whole Exome Sequencing 7.2.2.2.3. Others 7.2.2.3. Quality Control 7.2.3. By Technology 7.2.3.1. Sequencing By Synthesis (Sbs) 7.2.3.2. Ion Semiconductor Sequencing 7.2.3.3. Single-Molecule Real-Time Sequencing (Smrt) 7.2.3.4. Nanopore Sequencing 7.2.3.5. Others 7.2.4. By Application 7.2.4.1. Diagnosis 7.2.4.1.1. Infectious Disease 7.2.4.1.2. Cancer Diagnostics 7.2.4.1.3. Reproductive Health Diagnostics 7.2.4.2. Drug Discovery, 7.2.4.3. Agricultural & Animal Research 7.2.4.4. Others 7.2.5. By End-User 7.2.5.1. Academic Institutes & Research Centers 7.2.5.2. Hospitals & Clinics 7.2.5.3. Pharmaceutical & Biotechnology Companies 7.2.5.4. Others 7.2.6. By Country 7.2.6.1. Germany 7.2.6.2. UK 7.2.6.3. France 7.2.6.4. Italy 7.2.6.5. Rest of Europe 7.2.7. Company Market Share (Top 3-5) 7.2.8. Economic Impact Study on Europe NGS Sample Preparation Market 8. Asia Pacific NGS Sample Preparation Market Overview 8.1. Asia Pacific NGS Sample Preparation Market Size & Forecast, 2016-2027 8.1.1. Demand 8.1.1.1. By Value (USD Million) 8.2. Asia Pacific NGS Sample Preparation Market Share & Forecast, 2016-2027 8.2.1. By Product 8.2.1.1. Reagent & Consumables 8.2.1.2. Workstations 8.2.2. By Workflow 8.2.2.1. Library Preparation 8.2.2.1.1. DNA 8.2.2.1.2. RNA 8.2.2.2. Target Enrichment 8.2.2.2.1. Targeted Sequencing 8.2.2.2.2. Whole Exome Sequencing 8.2.2.2.3. Others 8.2.2.3. Quality Control 8.2.3. By Technology 8.2.3.1. Sequencing By Synthesis (Sbs) 8.2.3.2. Ion Semiconductor Sequencing 8.2.3.3. Single-Molecule Real-Time Sequencing (Smrt) 8.2.3.4. Nanopore Sequencing 8.2.3.5. Others 8.2.4. By Application 8.2.4.1. Diagnosis 8.2.4.1.1. Infectious Disease 8.2.4.1.2. Cancer Diagnostics 8.2.4.1.3. Reproductive Health Diagnostics 8.2.4.2. Drug Discovery, 8.2.4.3. Agricultural & Animal Research 8.2.4.4. Others 8.2.5. By End-User 8.2.5.1. Academic Institutes & Research Centers 8.2.5.2. Hospitals & Clinics 8.2.5.3. Pharmaceutical & Biotechnology Companies 8.2.5.4. Others 8.2.6. By Country 8.2.6.1. China 8.2.6.2. India 8.2.6.3. Japan 8.2.6.4. Australia 8.2.6.5. Rest of Asia Pacific 8.2.7. Company Market Share (Top 3-5) 8.2.8. Economic Impact Study on Asia Pacific NGS Sample Preparation Market 9. South America NGS Sample Preparation Market Overview 9.1. South America NGS Sample Preparation Market Size & Forecast, 2016-2027 9.1.1. Demand 9.1.1.1. By Value (USD Million) 9.2. South America NGS Sample Preparation Market Share & Forecast, 2016-2027 9.2.1. By Product 9.2.1.1. Reagent & Consumables 9.2.1.2. Workstations 9.2.2. By Workflow 9.2.2.1. Library Preparation 9.2.2.1.1. DNA 9.2.2.1.2. RNA 9.2.2.2. Target Enrichment 9.2.2.2.1. Targeted Sequencing 9.2.2.2.2. Whole Exome Sequencing 9.2.2.2.3. Others 9.2.2.3. Quality Control 9.2.3. By Technology 9.2.3.1. Sequencing By Synthesis (Sbs) 9.2.3.2. Ion Semiconductor Sequencing 9.2.3.3. Single-Molecule Real-Time Sequencing (Smrt) 9.2.3.4. Nanopore Sequencing 9.2.3.5. Others 9.2.4. By Application 9.2.4.1. Diagnosis 9.2.4.1.1. Infectious Disease 9.2.4.1.2. Cancer Diagnostics 9.2.4.1.3. Reproductive Health Diagnostics 9.2.4.2. Drug Discovery, 9.2.4.3. Agricultural & Animal Research 9.2.4.4. Others 9.2.5. By End-User 9.2.5.1. Academic Institutes & Research Centers 9.2.5.2. Hospitals & Clinics 9.2.5.3. Pharmaceutical & Biotechnology Companies 9.2.5.4. Others 9.2.6. By Country 9.2.6.1. Brazil 9.2.6.2. Argentina 9.2.6.3. Rest of South America 9.2.7. Company Market Share (Top 3-5) 9.2.8. Economic Impact Study on South America NGS Sample Preparation Market 10. Middle East & Africa NGS Sample Preparation Market Overview 10.1. Middle East & Africa NGS Sample Preparation Market Size & Forecast, 2016-2027 10.1.1. Demand 10.1.1.1. By Value (USD Million) 10.2. Middle East & Africa NGS Sample Preparation Market Share & Forecast, 2016-2027 10.2.1. By Product 10.2.1.1. Reagent & Consumables 10.2.1.2. Workstations 10.2.2. By Workflow 10.2.2.1. Library Preparation 10.2.2.1.1. DNA 10.2.2.1.2. RNA 10.2.2.2. Target Enrichment 10.2.2.2.1. Targeted Sequencing 10.2.2.2.2. Whole Exome Sequencing 10.2.2.2.3. Others 10.2.2.3. Quality Control 10.2.3. By Technology 10.2.3.1. Sequencing By Synthesis (Sbs) 10.2.3.2. Ion Semiconductor Sequencing 10.2.3.3. Single-Molecule Real-Time Sequencing (Smrt) 10.2.3.4. Nanopore Sequencing 10.2.3.5. Others 10.2.4. By Application 10.2.4.1. Diagnosis 10.2.4.1.1. Infectious Disease 10.2.4.1.2. Cancer Diagnostics 10.2.4.1.3. Reproductive Health Diagnostics 10.2.4.2. Drug Discovery, 10.2.4.3. Agricultural & Animal Research 10.2.4.4. Others 10.2.5. By End-User 10.2.5.1. Academic Institutes & Research Centers 10.2.5.2. Hospitals & Clinics 10.2.5.3. Pharmaceutical & Biotechnology Companies 10.2.5.4. Others 10.2.6. By Country 10.2.6.1. Saudi Arabia 10.2.6.2. UAE 10.2.6.3. South Africa 10.2.6.4. Rest of Middle East & Africa 10.2.7. Company Market Share (Top 3-5) 10.2.8. Economic Impact Study on Middle East & Africa NGS Sample Preparation Market 11. Competitor Analysis 11.1. Company Description 11.2. Financial Analysis 11.3. Key Products 11.4. Key Management Personnel 11.5. Contact Address 11.6. SWOT Analysis 11.7. Company Profile 11.7.1. Illumina Inc. 11.7.2. Thermo Fisher Scientific 11.7.3. QIAGEN N.V. 11.7.4. Agilent Technologies, Inc. 11.7.5. Beckman Coulter 11.7.6. Becton 11.7.7. Dickinson and Company 11.7.8. Pacific Biosciences of California 11.7.9. PerkinElmer Inc. 11.7.10. F. Hoffmann-La Roche 11.7.11. New England Biolabs, Inc. 11.7.12. NuGEN Technologies 11.7.13. Other Prominent Players
| Price : US$ 3500 | Date : Mar 2024 |
| Category : Manufacturing and Construction | Pages : 160 |
| Price : US$ 3500 | Date : Mar 2024 |
| Category : Medical Devices | Pages : 232 |
| Price : US$ 3500 | Date : Feb 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 134 |
| Price : US$ 3500 | Date : Feb 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 134 |
| Price : US$ 3500 | Date : Feb 2024 |
| Category : Energy, Mining and Utilities | Pages : 123 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
